REPL
Replimune Group Inc
13.50$
+4.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +185.5% | +136.9% | +51.7% | +132.0% | -15.1% | +40.2% | -24.6% | +13.0% | -39.7% | |
| – | +188.8% | +117.9% | +23.6% | +177.6% | -16.5% | +46.7% | -26.8% | +14.3% | -43.7% | |
| – | -14.6% | +46.2% | +131.5% | +206.8% | -42.0% | +38.4% | -49.2% | +49.2% | +88.1% | |
| – | +198.9% | +119.0% | +25.0% | +182.6% | -16.9% | +47.4% | -27.9% | +15.0% | -44.4% | |
| – | +69.8% | +3.6% | +19.7% | -0.3% | +3.5% | -3.8% | +67.5% | -24.3% | -56.5% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +8.2% | +3,186.2% | +378.7% | -87.2% | +646.8% | – | – | – | – | |
| – | +171.5% | -82.3% | +205.9% | -11.9% | +12.6% | +82.7% | +24.0% | +19.7% | +22.7% | |
| – | +160.2% | +91.4% | +20.1% | +22.5% | +42.7% | +63.0% | +19.6% | +54.2% | -6.6% | |
| – | – | – | – | +5.3% | +5.1% | +3.4% | +3.2% | +2.7% | +1.5% | |
| – | +517.0% | +255.4% | -51.5% | -31.4% | +58.5% | +43.7% | -51.9% | +383.4% | -46.5% | |
| – | – | – | +49.4% | – | – | – | +56.4% | +3.5% | +79.6% | |
| – | – | – | +33.3% | +171.5% | -17.5% | +35.0% | -32.6% | +11.0% | -60.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -24.8% | +47.7% | +35.0% | +12.9% | +11.5% | +14.4% | +21.0% | +15.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.